RISING PHARMACEUTICALS: Drug Recall
Recall #D-0573-2022 · 02/07/2022
Class II: Risk
Recall Details
- Recall Number
- D-0573-2022
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- RISING PHARMACEUTICALS
- Status
- Ongoing
- Date Initiated
- 02/07/2022
- Location
- East Brunswick, NJ, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2220 100-count bottles
Reason for Recall
Failed Tablet Specifications: Recall of this drug product was voluntarily initiated by the manufacturer due to a market complaint, which stated that a tablet in the sealed bottle was twice larger in size when compared to the remaining tablets. This complaint is second of its kind.
Product Description
Methylphenidate Hydrochloride Chewable Tablets, 2.5 mg, 100-count bottle, Rx Only, Manufactured for: Rising Pharmaceuticals Inc., Saddle Brook, NJ 07863, NDC 64980-221-01
Distribution Pattern
Nationwide in the USA
Other Recalls by RISING PHARMACEUTICALS
- Class II: Risk 02/15/2023
- Class II: Risk 09/02/2021
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.